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BACKGROUND: Leukemia inhibitory factor (LIF) is a pleiotropic cytokine that is essential for blastocyst implan-
tation in mice. It has been suggested that LIF may play a role in human ﬁrst trimester extravillous trophoblast
(EVT) invasion. The aim of the present study was to establish whether LIF induces changes in EVT function
related to invasiveness. METHODS: Primary ﬁrst trimester human EVT cell cultures were treated with/without
LIF and the effects on cell adhesion to ﬁbronectin (FN), vitronectin (VN) and laminin (LN) were assessed. Transcript
levelsofintegrinsubunitsthatmediatecelladhesiontothese extracellularmatrix(ECM)elementsweredeterminedby
real-time RT–PCR. Matrix metalloproteinase (MMP)2 and MMP9 secretion was assessed by gelatine zymography
and tissue inhibitors matrix metalloproteinase (TIMP) -1 and TIMP-2 secretion by enzyme-linked immunosorbent
assay. RESULTS: EVT cells showed increased adhesion to FN, VN and LN ECM elements in response to LIF (20,
20 and 29%, respectively, P<0.05 FN and VN compared to control; and P<0.001 LN compared to control). Integrin
b4 mRNA levels decreased by 50% following LIF treatment (P<0.001 versus control). MMP2 and MMP9 secretion
was not affected by LIF but LIF did increase secretion of TIMP-1 and -2 (P<0.001 versus control). LIF stimulated the
phosphorylation of signal transducer and activator of transcription (STAT) 3 protein while it did not affect STAT3
protein abundance. The addition of a LIF inhibitor attenuated the LIF-induced STAT3 phosphorylation in EVT.
CONCLUSION: The results suggest that LIF can regulate EVT invasion, suggesting an important role in early pla-
cental development.
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Introduction
In human placenta, cytotrophoblasts show two distinct
patterns of differentiation. In ﬂoating villi, they differentiate
into syncytiotrophoblast and form the syncytial layer. In con-
trast, at villus-anchoring sites, cytotrophoblasts form the stra-
tiﬁed structure known as the cell column and differentiate
into extravillous trophoblasts (EVTs) (Kaufmann and
Castellucci, 1997). EVTs acquire invasive activity in the
distal part of the cell column (Damsky et al., 1992) and
begin to migrate towards maternal tissue. Those that
migrate into the decidual tissue are called interstitial tropho-
blasts and those that migrate into the trophoblast shell and
invade along the maternal vessels are known as endovascular
trophoblasts.
Normal placental development depends on the ability of EVTs
to attach to and then invade into the maternal decidua and the
ﬁrst third of the myometrium. This occurs in order to anchor
the fetus to the maternal endometrium and then invade the
maternal spiral arteries creating large-diameter, low resistance
vessels that provide a means of steady perfusion of the ﬂoating
villi with maternal blood (Genbacev et al., 1992; Irving et al.,
1995; Aboagye-Mathiesen et al., 1996). Insufﬁcient trophoblast
invasion of the spiral arteries has been associated with pre-
eclampsia and fetal growth restriction (Hustin et al., 1990;
Kadyrov et al., 2006). A recent study shows that late sporadic
miscarriage is associated with abnormal trophoblast invasion
and insufﬁcient myometrial spiral artery transformation (Ball
et al., 2006). Identiﬁcation of the factors that control trophoblast
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enable better understanding of the etiology of these disorders.
Trophoblast invasion depends on a tightly controlled
program of intercellular signaling mediated by growth
factors, cytokines and hormones of both fetal and maternal
origin (Meisser et al., 1999; Bischof and Campana, 2000).
Cell adhesion molecules on the surface of EVTs play an
important role in the process of entry of EVTs into the maternal
decidua (Damsky et al., 1993; Zhou et al., 1993; Irving et al.,
1995). For the invasion of EVTs, cell–cell and/or
cell-extracellular matrix (ECM) interactions mediated by
adhesion molecules, such as cadherins and/or integrins, has
been considered to be important (Burrows et al., 1996).
These molecules provide the appropriate adhesion to enable
traction and movement of the cells and/or impart signal
between the ECM and the cell interior. When trophoblast
cells acquire the invasive phenotype in the cell column, down-
regulation of the integrin a6b4 and up-regulation of integrin
a5b1 occurs (Damsky et al., 1992). In addition, these cell
surface integrins modulate trophoblast motility (Damsky
et al., 1994) by interactions with certain ECM components
(Irving and Lala, 1995). For example, ﬁbronectin (FN) is abun-
dant where anchoring villi are formed in vivo and both tropho-
blast and maternal derived FN contribute to the ECM
encountered by EVT as they inﬁltrate the decidua. Thus, FN
acts as a bridging ligand mediating anchorage and/or
migratory activity following the interaction with the cognate
a5b1 integrin receptor of EVTs (Ilic et al., 2001).
Invasion also involves degradation of ECM elements in the
direction of migration and this requires the action of proteases,
particularly the matrix metalloproteinases (MMP)2 and 9
(Shimonovitz et al., 1994; Staun-Ram et al., 2004), whose
activity is physiologically regulated, at least in part, by tissue
inhibitors of metalloproteinases (TIMP) which bind the
MMPs with a 1:1 stoichiometry: thus the balance between
MMPs and TIMPs locally at the invasive site is important.
Leukemia inhibitory factor (LIF) is a pleiotrophic cytokine
and has known roles in implantation in mice (Bhatt et al.,
1991; Shen and Leder, 1992; Stewart et al., 1992; Vogiagis
and Salamonsen,1999;Kimber, 2005)and has parallelfunctions
in humans (Charnock-Jones et al., 1994; Kojima et al., 1994;
Arici et al., 1995; Delage et al., 1995; Laird et al., 1997;
Hambartsoumian, 1998). LIF signal transduction occurs via
the JAK/STAT signal transduction pathway (Heinrich et al.,
1998; White et al., 2007). LIF is highly expressed in ﬁrst
trimester decidua and the localization of its receptor on
trophoblast cells suggests paracrine actions during placentation
(Kojima et al., 1994; Sawai et al., 1995; Nachtigall et al.,
1996; Ren et al., 1997; Sharkey et al., 1999; Kayisli et al.,
2002; Chen et al., 2004). Strong expression of LIF mRNA has
also been detected in decidual leukocytes, which are abundant
at the implantation site, suggesting that LIF may mediate inter-
actions between maternal decidual leukocytes and invading tro-
phoblast cells (Sharkey et al., 1999). In this context, decreased
production of LIF mRNA by decidual T cells is associated
with unexplained recurrent abortions (Piccinni et al., 2000).
To determine whether LIF acts in a paracrine manner within
the developing placenta to modulate the invasive capacity of
trophoblast, we examined the effects of LIF on primary tropho-
blast cells derived from ﬁrst trimester decidua, with a focus on
their adhesive capacity, expression of adhesion molecules and
production of MMPs and TIMPs.
Materials and Methods
Tissue collection
Normal ﬁrst trimester placental tissue was obtained from healthy
women of reproductive age who underwent elective termination of
pregnancy (amenorrhea: 8–12 week, n ¼ 14). The study was
approved by the Southern Health Human Research and Ethics com-
mittee. Written informed consent was obtained from each patient
before surgical intervention. Chorionic villi were washed four times
in sterile saline and transferred to ice-cold medium 199 (M199) con-
taining antibiotic–antimycotic (Invitrogen, Carlsbad, CA, USA)
before transporting to the laboratory for further processing within 2 h.
EVT cell preparation
Primary EVT cells were prepared from chorionic villi as previously
described (Irving et al., 1995). Brieﬂy, terminal villi trees were
excised, washed twice and resuspended in diluted 1:3 growth factor
reduced (GFR) matrigel (BD Biosciences, Franklin Lakes, NJ,
USA). The villous tips were then transferred to ﬂasks and maintained
at 378C coated with GFR matrigel for 20 min to allow the matrigel to
set, followed by addition of Dulbecco’s modiﬁed Eagle’s medium
(DMEM)/F12 and 10% fetal calf serum (FCS) (Invitrogen).
Medium was changed every 3 days for 10–14 days to allow extensive
outgrowth. Outgrowing cells were detached by digestion with 0.03%
trypsin–EDTA (Invitrogen) in 0.9% phosphate-buffered saline
(PBS) for 5 min at 378C followed by neutralization of trypsin activity
with 10% FCS/M199. The dispersed cells were separated from large
tissue remnants using a 40 mm ﬁlter (BD Biosciences) and then placed
in culture to allow expansion for another 2–3 weeks. Cell cultures
were detached as above, incubated with anti-CD9 (Biosource Inter-
national, Camarillo, CA, USA) and subjected to negative immuno-
magnetic separation using MiniMacs columns (Miltenyi Biotech,
Bergisch-Gladbach, Germany) to eliminate CD9-positive placental
ﬁbroblast mesenchymal cells (Morrish et al., 1991; Yui et al., 1994).
The trophoblast cell fraction was washed three times and cells
seeded at a density of 10
6 cells/ml in DMEM/F12 supplemented as
above. To determine the purity of the immunopuriﬁed population
of EVT cells, cells were seeded on GFR Matrigel-precoated eight-
chamber culture slides, (Becton–Dickinson Labware). The human
EVT-hybridoma cell-line AC1M88 (Briese et al., 2005; Hannan
et al., 2006), to be used as a positive control, was seeded on uncoated
culture slides. AC1M88 and EVT cells were incubated in DMEM/
F12 medium (Sigma), supplemented with 10% FCS under standard
conditions for 24–48 h. Cells were then washed three times with
PBS, ﬁxed for 5 min with ice-cold ethanol, dried and stored at
2208C until immunohistochemistry for cytokeratin (CK7) and
HLA-G was performed. Only cell preparations in which .95% of
the cells were positive for CK7 were used for subsequent experiments.
EVT cells were cultured in T25 ﬂasks (Nunc) and grown to 60–70%
conﬂuency in DMEM/F12 containing 1% antibiotics (penicillin,
streptomycin and fungizone, Commonwealth Serum Laboratories,
Melbourne, VIC, Australia) and 10% FCS (complete medium). The
cells were washed twice with PBS free of Ca
2þ and Mg
2þ (PBS-)
and stepped down to DMEM/F12 supplemented with 0.2% FCS and
1% of antibiotics for 24 h. This medium was changed and LIF
(50 ng/ml; AMRAD, Melbourne, Australia) or vehicle (DMEM/F12)
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1725added. After a further 24 h cells were harvested, and conditioned
medium stored as aliquots 2208C until assayed.
Immunocytochemistry
Immunocytochemistry for the trophoblast-speciﬁc CK7 and the EVT-
speciﬁc marker HLA-G was performed on the cells using anti-human
CK7 (1:100 dilution, clone OV-TL 12/30, DakoCytomation,
Glostrup, Denmark) and anti-human HLA-G (1:200 dilution, clone
4H84, BD Pharmingen, San Diego, CA, USA), respectively. The
human EVT-hybridoma cell-line ACI.88 described elsewhere
(Hannan et al., 2006; Paiva et al., 2007) as used as a positive
control for the detection of both antigens. For the negative control,
non-immune mouse immunoglobulin (Ig)G (DakoCytomation) was
substituted for primary antibody at the same protein concentration.
Fixed cells on culture slides were rehydrated and treated with 3%
hydrogen peroxide in distilled water for 10 min to block endogenous
peroxidase activity. Cells were then washed with tris buffered saline
(TBS) and incubated with non-immune block for 30 min. Primary
antibody was applied and incubated at 48C for 16 h followed by bioti-
nylated horse anti-mouse IgG (1:200) for 30 min, then streptavidin–
biotin–peroxidase complex ABC (DakoCytomation) according to the
manufacturer’sinstructions.Peroxidaseactivitywasvisualizedbyappli-
cation of diaminobenzidine substrate (DakoCtyomation) for 3–5 min.
Cells were counterstained with Harris haematoxylin (Sigma), air dried
and mounted. Only cell preparations in which .95% of the cells
were positive for CK7 were used for subsequent experiments.
RNA preparation and quantitative real-time RT–PCR
EVT cells were treated with or without LIF (50 ng/ml) for 24 h. EVT
cell cultures were lysed with RLT buffer (QIAGEN, Germantown,
MD, USA) and stored at 2808C until used. Total RNA was extracted
from samples with the RNeasy Minikit (QIAGEN) according to the
manufacturer’s protocol. Genomic DNA contamination was
removed by RNase-free DNase set (QIAGEN). RNA yield, purity
and concentration were determined by spectrophotometry and 1 mg
of each RNA was run on a 1% agarose gel (Roche, Castle Hill,
NSW, Australia) to ensure RNA integrity.
Two micrograms of RNA was converted to complementary DNA
(cDNA) by using Superscript III RNA polymerase, random primer,
RNase inhibitor (RNaseOUT), deoxynucleoside triphosphates and
First-Strand buffer (Invitrogen) according to the manufacturer’s
protocol. Real-time PCR analyses were performed on the Prism
7500 real-time PCR system (Applied Biosystems, Foster City, CA,
USA) in triplicate (ﬁnal reaction volume, 25 ml) in 96-well Micro
Optical plates (Applied Biosystems). For each sample, 25 ng of
cDNA was added to a PCR mix made with the ﬁve times Fast-Start
SYBR green master mix containing Rox (Roche Diagnostics, Indiana-
polis, IN, USA) and 400 nM of primers. The sequences for the primers
are shown in Table I. The PCR protocol was: 508C for 2 min; 958C for
10 min; and 40 cycles of 958C for 15 s followed by 608C for 1 min.
Relative expression levels were calculated by the comparative cycle
threshold method (DDCt) as outlined in the manufacturer’s user
manual, with b-actin serving as the endogenous control for normaliza-
tion. The entire real-time RT–PCR run was performed twice.
ECM and adhesion molecule quantitative PCR arrays
Screening for the expression of 83 genes associated with cell adhesion
and ECM molecules in EVT cell cultures under control conditions
(n ¼ 2, triplicate arrays per EVT culture) was conducted using the
Human ECM and Adhesion Molecules RT2 Proﬁler PCR array
(SuperArray Bioscience Corp., Frederick, MD, USA) according to
the manufacturer’s instructions. In brief, cDNA was prepared from
1 mg total RNA by using a RT2 PCR array ﬁrst strand kit. PCR ampli-
ﬁcation was conducted with an initial 10-min step at 958C followed by
40 cycles of 958C for 15 s and 608C for 1 min. The ﬂuorescent SYBR
Green signal was detected immediately after the extension step of each
cycle, and the cycle at which the product was ﬁrst detectable was
recorded as the cycle threshold. Data were imported into an Excel
database and analysed using the comparative cycle threshold
method with normalization of the raw data to b-actin.
Cell adhesion assays
EVTcellsweretreatedwithorwithoutLIF(50 ng/ml)for24 h.Cellswere
then washed with PBS-, dissociated in trypsin–EDTA, rinsed twice in
PBS- and resuspended in DMEM. EVT cells were plated in triplicate at
2   10
4cells/well on 96-well FN, vitronectin (VN), laminin (LN) or
bovineserum albumin-coated CytoMatrixcelladhesionstrips(Chemicon
International, Inc.) according to the manufacturer’s instructions and
incubated at 378C for 1 h. Cells were rinsed three times with PBS
containing calcium and magnesium and stained for 5 min with 0.2%
crystal violet dissolved in 10% ethanol. After ﬁve washes with PBS,
crystal violet was eluted with 0.1 M NaH2PO4 containing 50% ethanol
for 15 min and the optical densities (OD) were measured at 570 nm.
Gelatin zymography for latent and active forms of MMP2
and MMP9
Both latent and active forms of MMP2 and MMP9 were analysed in
culture medium by zymography on 10% sodium dodecyl sulphate
(SDS)–polyacrylamide gels containing 1 mg/ml gelatine (all reagents
from Bio-Rad, North Ryde, Australia) under non-reducing conditions.
Culture medium from baby hamster kidney cells that had been stably
transfected with human MMP9 (Edwards, University of East Anglia,
Norwich, UK) was used for MMP2 and MMP9 standards as described
previously (Salamonsen et al., 1997). MMP identity of all bands was
conﬁrmed by incubation of parallel gels in the presence of EDTA
(5 mmol/l) and by activation of latent enzymes by incubation of the
culture medium with 4-aminophenyl mercuric acid (APMA) for 3 h
at 378C prior to running on a gel. Gelatinase activity was visualized
by negative staining and semi-quantiated by densitometric analysis
of zymograms as previously described (Salamonsen et al., 1997).
All samples for comparison were run on the same gel.
TIMP-1 and -2 enzyme-linked immunosorbent assay
TIMP-1 and -2 protein secreted from primary EVT cells was assayed
by enzyme-linked immunosorbent assay (ELISA) (R&D Systems Inc.,
Table I. Sequences for primers used in the quantitative analysis of mRNA
by real-time RT–PCR.
Gene Description Primer sequences 50-30 (forward/reverse)
ACTB b-Actin AGCCTCGCCTTTGCCGA/
GCGCGGCGATATCATCATC
ITGA1 Integrin a1
subunit
GAAAACGTGACCCATGAGTTCA/
GAAAACGTGACCCATGAGTTCA
ITGA5 Integrin a5
subunit
GCCTGTGGAGTACAAGTCCTT/
AATTCGGGTGAAGTTATCTGTGG
ITGA6 Integrin a6
subunit
GCTGGTTATAATCCTTCAATATCAATTGT/
TTGGGCTCAGAACCTTGGTTT
ITGB1 Integrin b1
subunit
GTGGTTGCTGGAATTGTTCTTATT/
TTTTCCCTCATACTTCGGATTGAC
ITGB4 Integrin b4
subunit
CTGTGTGCACGAGGGACATT/
AAGGCTGACTCGGTGGAGAA
ITGAV Integrin aV
subunit
GAAAAGAATGACACGGTTGC/
AGTGATGAGATGGTCCCGCT
ITB3 Integrin b3
subunit
ACTGCCTGTGACTCCGACT/
CGCGTGGTACAGTTGCAGTAG
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1726Minneapolis, MN, USA). The conditioned media from primary EVT
cells were used in a 1:10 dilution to ensure that TIMP levels fell
within the range of the standards in the assays. The lower detection
limit of the assay was 0.08 ng/ml, and inter- and intra-assay variabil-
ity were ,7 and ,5%, respectively.
Western blot analysis for signal transducer and activator
of transcription 3 (STAT3) protein and phosphorylated
STAT3 in primary EVT cells
Conﬂuent EVT cells were either untreated or treated with LIF (50 ng/
ml) with or without a newly described superpotent LIF antagonist
(LA) (20 nM, White et al., 2007) for 15 min. The medium was aspi-
rated, and cells washed with ice-cold sterile PBS, twice on ice. Cells
were lysed and scraped in ice-cold lysis buffer containing 50 mM
Tris base, 150 mM NaCl, 2 mM EDTA, 2 mM EGTA, 25 mM NaF,
25 mM b-glycerolphosphate (pH 7.5) and 2 ml/well protease inhibi-
tors cocktail set III [4-(2-aminoethyl)benzenesulfonyl ﬂuoride,
100 mM HCl, 80 mM aprotinin, 5 mM bestatin, 1.5 mm E-64, 2 mM
leupeptin hemisulfate and 1 mm pepstatin A (Calbiochem, San
Diego, CA, USA)]. Cell extracts were then centrifuged and super-
natant protein was quantiﬁed using the BCA protein assay kit
(Pierce, Rockford, IL, USA). Equal amounts of total protein were
then resolved by SDS–polyacrylamide gel electrophoresis and trans-
ferred to nitrocellulose membranes. All membranes were incubated
with Ponceau S (Sigma) to ensure equal protein loading in all lanes
(results not shown). The membranes were blocked with 5% non-fat
dry milk in TBS, washed and probed separately with antibodies
speciﬁc for phosphorylated STAT3 (Tyr705; Cell Signaling Techno-
logy Inc., Beverly, MA, USA) (1:1000) or total STAT3 (Cell
Signaling Technology) (1:1000). The membranes were washed and
then incubated with horse-radish peroxidase (HRP)-conjugated
rabbit secondary antibody (DakoCytomation, Glostrup, Denmark)
(1:1500). Finally, the HRP activity was detected using enhanced
chemiluminescence reagent (Pierce). The membranes were exposed
to autoradiographic ﬁlm (Amersham Biosciences, Little Chalfont,
UK) with the exposure time adjusted to keep the integrated OD
within a linear and non-saturated range.
Statistical analyses
Data are expressed as mean+SEM fold change for each treatment
compared to control. For each independent experiment treatment,
values were expressed as a percentage of controls and statistical analy-
sis was then carried out on the data from different experiments. Stat-
istical analysis was performed using the Mann–Whitney test when
comparing more than two groups or Student’s t-test when comparing
two groups (P , 0.05 was taken as signiﬁcant) using PRISM version
3.00 for Windows (GraphPad).
Results
Characterization of EVT cells
Immunocytochemical analyses of the cells cultured on
GFR-matrigel coated slides showed that CK7 and HLA-G
were present in .80% of the attached cells (Fig. 1A and B,
respectively). The choriocarcinoma-fusion cell line AC1M88
was used as a positive control for both antigens (Fig. 1D and
E). Replacement of primary antibodies with non-immune IgG
resulted in a lack of immunostaining (Fig. 1C and F).
Effect of LIF on EVT adhesion
To investigate whether LIF had an effect on the adhesion of tro-
phoblast to different ECM elements, trophoblast cells were
incubated on FN, LN or VN coated wells. In the unstimulated
state, trophoblast cells adhered more to FN compared to VN
and LN (Fig. 2A). When trophoblast cells were treated with
50 ng/ml of LIF for 24 h, there was a signiﬁcant increase of
Figure 1: Immunocytochemical staining of cytokeratin (CK)7 and HLA-G in primary extravillous trophoblast (EVT).
(A–C) Primary EVT cells. (A) CK7 staining. (B) HLA-G staining. (C) Negative control for B. (D-F) AC1M88 cells (human EVT-hybridoma) (D)
CK7 staining. (E) HLA-G staining. (F) Negative control for D. Scale bar ¼ 50 mm. Positive staining is brown.
Leukemia inhibitory factor: effects on trophoblast
1727binding to FN, VN and LN of 20, 20 and 29%, respectively
(P , 0.05 for FN and VN and P , 0.001 for LN, Mann–
Whitney test; Fig. 2B–D).
Expression proﬁle of adhesion molecules and ECM elements
in EVT cell cultures using PCR array
Since EVT cell cultures increased their adhesion to FN, LN and
VN upon treatment with LIF we reasoned that such changes
could be exerted via transcriptional regulation of those integrin
subunits that mediate the cell adhesion to these ECM elements.
As a ﬁrst step, we investigated whether the ECM and adhesion
molecule transcriptional expression proﬁle of cultured EVT
cells was similar to that of EVTs in vivo by a PCR array.
The expression of each screened gene is shown corrected for
b-actin in Table II. Signals were detected for 98.2% of the
genes screened in EVT cells under unstimulated culture con-
ditions. Genes were ranked from highest to lowest expression
Figure 2: Effect of leukemia inhibitory factor (LIF) on adhesion of
primary EVT cells to ﬁbronectin (FN), vitronectin (VN) and laminin
(LN).
(A) Adhesion proﬁle of EVT cells to FN, VN and LN under unstimu-
lated conditions. Data show two separate experiments assayed in tri-
plicate. (B–D) EVT cells were cultured with/without LIF (50 ng/
ml) for 24 h and the adhesion to FN (B), VN (C) and LN (D) screened.
Data represented as mean+SEM. Data show three independent
experiments. Each sample was assayed in triplicate. *P , 0.005,
**P , 0.001 compared to control.
Table II. Extracellular matrix and adhesion molecule mRNA expression in
primary human EVT cells studied using PCR array.
Symbol UniGene RefSeq Mean C Ct
COL1A1 Hs.172928 NM_000088 1.8
FN1 Hs.203717 NM_002026 2.9   10
21
THBS1 Hs.164226 NM_003246 1.4
COL6A2 Hs.420269 NM_001849 9.0
COL5A1 Hs.210283 NM_000093 8.2
TIMP1 Hs.522632 NM_003254 8.1   10
22
TGFBI Hs.369397 NM_000358 7.3
MMP2 Hs.513617 NM_004530 6.8
ITGB1 Hs.429052 NM_002211 6.8
CTGF Hs.410037 NM_001901 6.6
TIMP2 Hs.104839 NM_003255 5.1
COL4A2 Hs.508716 NM_001846 5.1
SPARC Hs.111779 NM_003118 4.2
COL12A1 Hs.101302 NM_004370 2.5
CTNNB1 Hs.476018 NM_001904 2.3
CSPG2 Hs.443681 NM_004385 1.6
CTNNA1 Hs.445981 NM_001903 1.6
TNC Hs.143250 NM_002160 1.5
THBS2 Hs.371147 NM_003247 9.1   10
23
LAMB1 Hs.489646 NM_002291 8.6
MMP1 Hs.83169 NM_002421 8.0
ITGA3 Hs.265829 NM_002204 7.1
ITGB5 Hs.13155 NM_002213 4.3
ITGAV Hs.436873 NM_002210 4.0
COL8A1 Hs.134830 NM_001850 3.7
ADAMTS1 Hs.534115 NM_006988 2.7
KAL1 Hs.521869 NM_000216 2.5
COL16A1 Hs.368921 NM_001856 2.4
ECM1 Hs.81071 NM_004425 2.2
ITGA2 Hs.482077 NM_002203 2.2
MMP16 Hs.546267 NM_005941 1.8
SPG7 Hs.185597 NM_003119 1.8
ITGA1 Hs.519304 NM_181501 1.2
ICAM1 Hs.515126 NM_000201 1.0
VCAM1 Hs.109225 NM_001078 9.2   10
24
LAMC1 Hs.497039 NM_002293 8.7
SGCE Hs.371199 NM_003919 6.6
ITGA4 Hs.553495 NM_000885 6.0
SPP1 Hs.313 NM_000582 5.8
THBS3 Hs.169875 NM_007112 5.0
ITGB3 Hs.218040 NM_000212 4.7
MMP13 Hs.2936 NM_002427 4.0
ITGA6 Hs.133397 NM_000210 3.9
COL6A1 Hs.474053 NM_001848 3.3
COL11A1 Hs.523446 NM_080629 2.7
MMP15 Hs.80343 NM_002428 2.5
MMP9 Hs.297413 NM_004994 2.0
NCAM1 Hs.503878 NM_000615 1.2
MMP11 Hs.143751 NM_005940 1.0
CTNND1 Hs.166011 NM_001331 7.7   10
25
ADAMTS13 Hs.131433 NM_139028 6.7
ITGA5 Hs.505654 NM_002205 6.6
COL14A1 Hs.409662 NM_021110 6.6
COL15A1 Hs.409034 NM_001855 5.7
LAMA2 Hs.200841 NM_000426 3.8
CNTN1 Hs.567249 NM_001843 2.9
ITGA7 Hs.524484 NM_002206 2.9
ITGB4 Hs.370255 NM_000213 2.8
ITGA8 Hs.171311 NM_003638 2.4
HAS1 Hs.57697 NM_001523 1.6
CLEC3B Hs.476092 NM_003278 1.4
LAMA3 Hs.436367 NM_000227 1.2
MMP3 Hs.375129 NM_002422 1.1
MMP8 Hs.534479 NM_002424 1.0
MMP10 Hs.2258 NM_002425 6.2   10
26
MMP14 Hs.2399 NM_004995 4.1
PECAM1 Hs.514412 NM_000442 4.0
CDH1 Hs.461086 NM_004360 3.8
LAMB3 Hs.497636 NM_000228 3.5
Continued
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1728levels. The protease inhibitors were some of the most highly
expressed genes in the EVT cells. The FN gene was also
highly expressed. Interestingly, VN was not detectable. Integ-
rin b1 showed the highest mRNA expression compared to all
other integrins screened. Integrins a1, a6 mRNA showed
moderate expression, while integrins a5 and b4 showed low
levels of gene expression.
Quantitative analysis of mRNA for integrin subunits in EVT
We investigates whether LIF regulated EVT integrin mRNA
expression in EVTs. Real-time RT–PCR was performed on
EVT cell cultures untreated and treated with LIF for those
integrin subunits listed in Table I. A mean DDCt value of .1
reﬂects increased and a value of ,1 points to a decreased
gene expression compared to control. The calculated ratios
of corrected transcript levels between treated and control
cells showed a change only for integrin b4 whose expression
level decreased approximately 50% on treatment with LIF
(P , 0.05, Fig. 3).
Effect of LIF on MMP2 and MMP9 mRNA expression
and enzyme production in EVT
The proﬁle of MMP2 and MMP9 secreted from EVT cells
treated and untreated with LIF was examined by gelatine
zymography. Unstimulated EVT cells secreted both MMP2
and MMP9 in their latent forms and in some cultures a weak
band corresponding to active MMP2 was found. No active
MMP9 was detected. However, the active forms of both
MMP2 and MMP9 could be induced by APMA treatment
in vitro (Fig. 4A). There were no signiﬁcant differences in
MMP secretion following LIF treatment of EVT cells as
shownby densitometricanalyses of zymograms(Fig. 4B and C).
Effect of LIF on TIMP-1 and -2 secretion from EVT
Since the activities of MMP2 and MMP9 after activation are
regulated by TIMPs, we analysed the levels of TIMP-1 and
TIMP-2 protein in culture medium from EVT cells, without
and following LIF treatment, by ELISA. Both TIMPs were sig-
niﬁcantly increased following treatment of EVT cells with LIF
(Fig. 5, P , 0.05). Real-time RT–PCR measurement of
TIMP-1 and -2 mRNAs was also carried out in the treated
Figure 3: Effect of leukemia inhibitory factor (LIF) on integrin
mRNA expression in primary EVT cells.
EVT cells were treated with LIF (50 ng/ml for 24 h). Real-time RT–
PCR data for integrin (ITG) a1, a5, a6, aV, b1, b3, b4 are presented as
ratios obtained by the comparative cycle threshold method (DDCt)
method, corrected to b-actin. Data represented as mean+SEM.
Data show three independent experiments. Each sample was assayed
in triplicate. *P , 0.001 compared to control.
Figure 4: Effect of leukemia inhibitory factor (LIF) on matrix metal-
loproteinase (MMP)2 and MMP9 secretion from primary EVT cells.
Cells were treated with/without LIF (LIF, 50 ng/ml) for 24 h. Cells
were treated with aminomercuric acid (APMA) for 3 h at 378C to acti-
vate MMP2 and MMP9. Standard (Std) from conditioned culture
medium of BHK9 breast carcinoma cells. (A) Representative gelatin
zymogram of three separate experiments illustrating pro (or latent)
and active (act)MMP2 and MMP9. (B) Densitometric analysis of
proMMP2. (C) Densitometric analysis of proMMP9. (B and C) Data
represented as mean+SEM. Data show three independent exper-
iments. Each sample was assayed in duplicate.
Table II. Continued
Symbol UniGene RefSeq Mean C Ct
CTNND2 Hs.314543 NM_001332 2.4
MMP7 Hs.2256 NM_002423 2.2
ADAMTS8 Hs.271605 NM_007037 7.6   10
27
TIMP3 Hs.297324 NM_000362 6.6
SELE Hs.89546 NM_000450 4.5
MMP12 Hs.1695 NM_002426 3.8
ITGAL Hs.174103 NM_002209 1.9
ITGAM Hs.172631 NM_000632 1.2
COL7A1 Hs.476218 NM_000094 undetectable
ITGB2 Hs.375957 NM_000211 undetectable
LAMA1 Hs.270364 NM_005559 undetectable
SELL Hs.82848 NM_000655 undetectable
SELP Hs.73800 NM_003005 undetectable
VTN Hs.2257 NM_000638 undetectable
Ranked gene expression in human extravillous trophoblast cells. Data is
presented as the mean of the threshold cycle values for each transcript
corrected to b-actin (mean C Ct).
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LIF treatment (data not shown).
Effect of LIF on STAT3 phosphorylation in EVT
To determine the speciﬁcity and response of LIF action in EVT
cells we examined the effect of blocking LIF action with a
newly described LA, on LIF induced STAT3 phosphorylation.
The effect of LIF on phosphorylation of STAT3 and STAT3 in
EVT was examined over a 15-min time period by Western blot
(Fig. 6). Addition of LIF to EVT cells stimulated phosphoryl-
ation of STAT3 at 15 min while co-culture of cells with LIF
and a superpotent LA diminished the effect, compared with
cells treated with LIF alone for 15 min (Fig. 6, top). STAT3
protein abundance was not affected at any time point when
LIF was added to EVT (Fig. 6, bottom).
Discussion
This study examined effects of LIF on human EVT cells and
demonstrated that LIF stimulated their adhesion to ECM
elements, decreased integrin b4 mRNA expression and stimu-
lated production of TIMP-1 and -2, suggesting a role for LIF
during human placental development. The effect of LIF on
the invasive potential of human EVT cells has been controver-
sial. LIF has been reported to increase fetal FN secretion and
decrease gelatinase activity by ﬁrst-trimester trophoblast
cells, suggesting an overall inhibitory effect on trophoblast
invasion (Bischof et al., 1995; Nachtigall et al., 1996).
However,anotherreportshowedthatLIFincreasedtheinvasion
of ﬁrst trimester EVT cells in vitro (Poehlmann et al., 2005).
EVT cell invasion through the maternal decidua involves the
adhesion, migration and invasion of EVT. EVT cell invasion is
regulated by locally derived factors as well as by interactions of
EVT with certain ECM components through integrins expressed
inthecellsurface(IrvingandLala,1995).Intheﬁrsttrimesterof
pregnancy trophoblast invasion is tightly controlled. Taking a
functional approach, we investigated the effect of LIF stimu-
lation on EVT cell adhesion to some components of the ECM.
We found that LIF increased the adhesion of EVT cells, a
result that is relevant in the context of cell migration. Pregnan-
cies complicated by pre-eclampsia or intrauterine growth retar-
dation are characterized by shallow trophoblast invasion, and
may result from failure to express the correct spectrum of integ-
rins for trophoblast invasion (Nachtigall et al., 1996). Integrins
change in expression as trophoblast differentiates from the
villous to extravillous phenotype. Cytotrophoblast progression
through the cell column and differentiation into the invasive
phenotype is normally characterized by down-regulation of the
integrin a6b4, which may be a receptor of LN (Damsky et al.,
1992; Aplin, 1997). Conversely, cells in the column up-regulate
theirproductionofthe major FNreceptor,a5/b1 (Damsky et al.,
1992).TheproﬁleofintegrinmRNAexpressedbytheEVT cells
in our study suggest that they are of the invasive phenotype.
Integrin b1 mRNA was maximally expressed, while integrin
a5 mRNA was minimally expressed. Integrins a6 and b4
mRNA were moderately to minimally expressed relative to the
other integrins screened.
The adhesion proﬁle on untreated resting EVT cell cultures
in the present study was FN . VN . LN, similar to the proﬁle
previously demonstrated for HTR8/SVneo trophoblast cells
that closely resemble (Spessotto et al., 2006) the phenotype
of EVT cells. To identify relative levels of ECM and adhesion
molecule mRNA expression in EVT cells we used real-time
RT–PCR ECM and adhesion molecule speciﬁc arrays. We
found that all the major adhesion molecules were expressed
by EVTs.
Importantly, when EVT cells were treated with LIF we found
an increase in adhesion of the cells to all three matrices with
the greatest increase in adhesion to LN. Since cytotrophoblast
progression through the cell column is associated with a
downregulation of the integrin a6b4 (a likely LN receptor),
our demonstration of a reduction in expression of the b4
subunit, is consistent with a role for LIF in the differentiation
of trophoblast cells to the invasive phenotype. The lack of
effectofLIFonotherintegrinsubunitsinourstudysupportspre-
vious ﬁndings using ﬂuorescence-activated cell sorter analysis,
which showed no effect of LIF on the expression of the integrin
subunits a1, a5 and b1 by EVT cells (Sharkey et al., 1999).
The increase in cell adhesion to ECM elements without
changes in the expression levels of the respective integrins sub-
units is interesting. In this regard, it has been shown that EVT
Figure 5: Effect of leukemia inhibitory factor (LIF) on tissue inhibi-
tors of matrix metalloproteinase (TIMP)-1 and -2 protein secretion
from primary EVT cells into culture medium.
Cells were treated with/without LIF (LIF, 50 ng/ml) for 24 h.
(A) TIMP-1 secretion. (B) TIMP-2 secretion. Data represented as
mean+SEM. Data show three independent experiments. Each
sample was assayed in duplicate. *P , 0.001 compared to control.
Figure 6: Leukemia inhibitory factor (LIF) induced phosphorylation
in EVT cells.
EVT cells were cultured with LIF (50 ng/ml) for 15 min, and LIF plus
superpotent LIF antagonist (LA, 20 mM) for 15 min. Cell lysates were
electrophoresed by sodium dodecyl sulphate–polyacrylamide gel
electrophoresis and immunoblotted with anti-p(Tyr705)STAT3 (phos-
phorylated signal transducer and activator of transcription, top) or
anti-STAT3 (bottom) followed by horse-radish peroxidase-conjugated
rabbit antiserum and chemiluminescence visualization. The data
shown is from a single experiment but is representative of two inde-
pendent experiments.
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including chemokines (Luo et al., 2007). Thus, it is likely
that in vivo, a variety of factors, including LIF, act in concert
to regulate EVT integrins.
Paradoxically, the integrin b4 subunit, that is regulated by
LIF, dimerizes with the integrin a6 subunit to form the possible
LN receptor. At the same time, the highest increase in EVT cell
adhesion upon LIF treatment was to LN. Cells control adhesion
via integrins by regulating the amount of integrins expressed on
thecellsurfaceandalsobymodulatingtheafﬁnityofintegrinsto
their substrates. It is possible that LIF does not regulate integrin
a6b4 cell surface protein production. It is also likely that factors
other than LIF affect the afﬁnity of integrin a6b4 on trophoblast
cells to LN. In addition, integrin a6b4 also potentially binds
other ECM components suggesting that EVT cells bind to LN
via mechanisms other than via integrin a6b4.
MMP2 and MMP9 have been implicated in trophoblast inva-
sion and migration (Campbell et al., 2003; Nardo et al., 2003)
and in one studyLIF decreased the overall gelatinolytic activity
of trophoblast cells (Bischof et al., 1995). We also showed that
secretion of latent and active forms of MMP2 and MMP9 by
ﬁrst trimester human EVT cells were not affected by LIF
stimulation although LIF increased both TIMP-1 and -2
secretion. Importantly, secreted MMP2 and MMP9 were pre-
dominantly in latent forms, suggesting that an important
level of regulation for their activity is by extracellular acti-
vation, probably by factors of maternal origin. The stimulation
of TIMP secretion by LIF would provide further modulation of
MMP action within the microenvironment of the EVT. This
supports the previous report that gelatinase activity is inhibited
in EVT cell cultures treated with LIF (Bischof et al., 1995). We
also veriﬁed that LIF was active in the EVT cells since
co-culture of the EVT cells with LIF and LA reduced
LIF-induced STAT3 activation and suggests that LIF regulated
EVT function via pSTAT3.
Our ﬁndings support a role for LIF on adhesion and differen-
tiation of trophoblast cells to the invasive phenotype, both of
which are involved in trophoblast invasion: a process that if
not ﬁnely regulated can result in abnormal placentation.
Indeed, an abnormally persistent expression of LIF receptor
on EVT cells in placental bed biopsies has been demonstrated
in patients with early onset pre-eclampsia combined with
intra-uterine growth reduction (Reister et al., 2006).
In conclusion, our data showed that LIF stimulated primary
ﬁrst trimester EVT cell adhesion to LN, VN and FN along with
reduced expression of the integrin b4 subunit. Furthermore,
LIF altered the balance between MMPs and TIMPs by increas-
ing the secretion of TIMP-1 and -2 without alteration of MMP2
or MMP9 secretion. Overall, these changes suggest that LIF
stimulates the differentiation of EVT cells toward the invasive
phenotype. The study suggests that LIF has an important role in
early placentation in women.
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